: Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake

<p>Eisai plans to apply for FDA approval of subcutaneous Leqembi by early next year. Read Full Story</p>
<p>The post <a rel="nofollow" href="https://forextv.com/market-news/biogen-and-eisai-release-new-alzheimers-drug-data-that-may-support-wider-uptake/">: Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>